Clinical trial
Treatment of Orthostatic Hypotension in Autonomic Failure
NCT00223691 · Vanderbilt University, Other · Completed
Key facts
| NCT number | NCT00223691 |
|---|---|
| Title | Treatment of Orthostatic Hypotension in Autonomic Failure |
| Official title | Evaluation and Treatment of Autonomic Failure. |
| Lead sponsor | Vanderbilt University, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Autonomic Failure, Orthostatic Hypotension |
| Intervention type | Device, Dietary Supplement, Drug, Other |
| Interventions | Atomoxetine, Acarbose, Pyridostigmine Bromide, Yohimbine, Midodrine HCl, placebo, Modafinil, Octreotide, water intake, Diphenhydramine Hydrochloride and 15 more |
| Enrollment | 389 |
| Start date | Mar 1, 2002 |
| Primary completion | Jan 1, 2017 |
| Completion | Jan 1, 2017 |
| First posted | Sep 22, 2005 |
| Last update posted | Jan 18, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: